High Tide x Remexian: A Clear Signal—and a Stress Test—for Germany’s Medical Cannabis Market
High Tide’s decision to acquire 51% of Remexian Pharma for a preliminary €27.2 million isn’t just another headline; it’s a calculated entry into Europe’s largest medical cannabis market with a player that already moves real volume and runs a fully certified EU-GDP warehouse. The agreement includes an option to buy the remaining stake and is […]
